Healthcare Policy

Healthcare Policy

Friends of Cancer Research Releases White Paper on Optimizing Dosing in Oncology Drug Development

Friends urges stakeholders in the cancer community to work together to optimize dosing in oncology drug development to maximize benefit for patients and reduce treatment toxicity... 

The ASCO Post
Biomarker Analysis Evaluates Potential for Immune Checkpoint Blockade Response in Older Patients With Cancer

A retrospective analysis of large data sets of biomarkers from tumors and healthy tissue by researchers suggests that older patients with cancer may benefit as much from cancer immunotherapies...

The ASCO Post
NHS to Trial Galleri Cancer Blood Test

The NHS is to recruit tens of thousands of people to take part in a trial of a blood test that aims to detect more than 50 types of cancer before symptoms appear.


Teleoncology for Veterans With Cancer During the COVID-19 Pandemic

In a single-center study, investigators find an overall high level of satisfaction with teleoncology care during the COVID-19 pandemic among veterans with cancer in the US...

The ASCO Post
Rates of Newly Diagnosed Cancer Among US Patients During the First Full Year of the COVID-19 Pandemic

Kaufman et al find significant decreases in monthly new cancer diagnoses during the first full year of the COVID-19 pandemic compared with the prepandemic period.

The ASCO Post
Update to NCCN: Cancer and COVID-19 Vaccination Guidance Announced

This is the fourth version of NCCN’s COVID-19 vaccination guide and incorporates the latest data plus recent approvals from the FDA and CDC regarding a third mRNA vaccine dose for immunocompromised

The ASCO Post
Early and Locally Advanced NSCLC: An Update of the ESMO Clinical Practice Guidelines Focusing on Diagnosis, Staging and Systemic and Local Therapy

An update of the ESMO Clinical Practice Guidelines for NSCLC treatment is provided. 

Update on U.S. Indication for Atezolizumab in PD-L1–Positive Metastatic Triple-Negative Breast Cancer

Genentech announced that it has made the decision to voluntarily withdraw the US accelerated approval for atezolizumab in combination with nab-paclitaxel for the treatment of adults with...

The ASCO Post
Study Finds Cannabis Use Is Lower Among Patients With Cancer Than Those With No Cancer History

In a recent study, researchers analyzed data over a span of 4 years.

The ASCO Post
FDA Alert: Clinical Trial Results Show an Increased Risk of Death Associated With Melphalan Flufenamide

The FDA is alerting patients and health-care professionals that a clinical trial evaluating melphalan flufenamide with dexamethasone to treat patients with MM showed an increased risk of death...

The ASCO Post
Two Doses of COVID-19 Vaccine Appear Necessary to Protect Cancer Patients on Active Treatment

Cancer patients on active treatment had a “pronounced lag” in antibody production after receiving the Pfizer-BioNTech COVID-19 vaccine, researchers reported in JAMA Oncology.

Cancer Therapy Advisor
Many Pandemic-Driven Changes to Cancer Clinical Trials Should Remain

Among the potential improvements were more efficient study enrollment through secure electronic platforms, direct shipment of oral drugs to patients, remote assessment of adverse events...

PPIs Could Be Bad News for Oral Cancer Therapies

A substantial proportion of patients with cancer use PPIs, and up to one-third of these patients are also using oral cancer treatments that could be adversely affected by concomitant PPI use.

Patient Support Improves Oral Antitumor Drug Safety

New oral antitumor drugs that have been approved since the early 2000s, like kinase inhibitors, have significantly improved outcomes for patients with many types of cancer.

Oncology Times - Latest Articles
CAR-T Cell Strategy to Target the Loss of Genes in Cancer

A team of researchers developed a new CAR-T cell approach to target a genetic change that commonly occurs in all types of cancer. This genetic alteration, termed LOH, occurs in cancer when...

Oncology Times - Latest Articles
Germline Genetic Testing for All Patients With Cancer?

Such testing can identify mutations that may warrant a change of treatment and allow trying a targeted therapy, and it can also guide screening for high-risk individuals and their family members.

Study Finds Need to Improve Knowledge About Palliative Care Among U.S. Adults

The use of palliative care in hospitals in the United States has steadily risen over the past decade, with almost universal access to services in large hospitals and academic medical centers.

The ASCO Post
Vaccine Shows Promise Against Multiple Tumor Types

Results from a Phase I clinical trial suggest that administration of a neoantigen vaccine developed using a computational platform cause no serious safety concerns while...

Oncology Times - Latest Articles
Oncology Hospital-at-Home Program Reduced Unplanned Health-Care Utilization and Costs

Mooney et al find that an oncology hospital-at-home program reduces unplanned health-care utilization and costs vs usual care among patients with cancer discharged from the hospital.

The ASCO Post
Study Finds Income Eligibility Limits for Medicaid May Be Associated With Worse Long-Term Survival Among Newly Diagnosed Patients With Cancer

A study investigating the association between state Medicaid income eligibility limits and long-term survival among newly diagnosed patients with cancer has found that patients living in states wit

The ASCO Post
Surveillance Protocol and Early Cancer Detection in Patients With Constitutional Mismatch Repair Deficiency Syndrome

Use of an IRRDC surveillance protocol is associated with improved OS among patients with CMMRD, a cancer predisposition syndrome associated with inheritance of biallelic pathogenic variants in mism

The ASCO Post
Possible Obesity Effect Detected in Cancer Death Rates

The obesity epidemic in the United States may be slowing improvements in cancer mortality, according to a new analysis of over 50 million cancer and heart disease deaths.

Effect of Oral Chemotherapy Management Program on Capecitabine Toxicity

This study finds that implementation of an oral CT management program is associated with reduced rates of any-grade and severe capecitabine toxicity, less frequent toxicity-related...

The ASCO Post
Vitamins to Prevent Cancer and CVD: No, Says USPSTF

For most vitamin and mineral supplements, there is not enough evidence to recommend for or against taking them to prevent cancer and CVD, according to new draft recommendations from the US Preventi

Safety and Immunogenicity of One versus Two Doses of the COVID-19 Vaccine BNT162b2 for Patients With Cancer

This study examines the safety and immunogenicity of the BNT162b2 vaccine in patients with cancer.

The Lancet Oncology
Effect of Antihypertensive Medications on Risk of Cancer

Emma Copland and colleagues find “no consistent evidence” of an association between antihypertensive treatment and risk for cancer. 

The ASCO Post
Advancing Cancer Care in the Black Community

African Americans face a higher burden from cancer compared to other racial/ethnic groups in the U.S., and an even greater obstacle to cancer prevention, detection, treatment, and survival.

Oncology Times - Latest Articles
Rankings of Most Common Cancers to Shift Over Next 20 Years

The next 20 years will see a big shift in cancer type rankings, researchers predict.

Study Evaluates Method to Reduce Medication Errors and Side Effects of Newer Oral Anticancer Drugs

Dürr et al found that an intensified clinical pharmacologic/pharmaceutical care initiative reduced medication errors and severe side effects among patients receiving newer oral anticancer drugs.

The ASCO Post
Cancer Screening Stopped by Pandemic: Repercussions to Come?

Last year, cancer screening programs around the world ground to a halt as SARS-CoV-2 infection rates surged globally. The effect of this slowdown is now becoming clear.

NCCN Issues Guidance on COVID-19 Vaccination for Patients With Cancer

Oncology groups including ASCO, ASH, and the American Society for Radiation Oncology have all recommended patients with cancer get vaccinated. Now the NCCN has published a similar guidance.

Oncology Times - Latest Articles
Medicaid Expansion Is Associated With Earlier Diagnosis of Gastric Cancer, Improved Survival

Medicaid expansion caused a decrease in uninsured patients and led to an earlier diagnosis of gastric cancer with an associated increase in 1-year survival.

The ASCO Post
Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain

This study examines the predictors for and frequency of the presence of nonmedical opioid use behavior in patients with cancer.

JAMA Oncology

source list reference

rgb(171, 222, 222)
rgb(219, 18, 118)
200, 66, 245
rgb(195, 2, 230)
rgb (247, 7, 79)
rgb(14, 133, 237)
rgb(252, 3, 223)
rgb(209, 15, 15)
rgb(115, 43, 196)
rgb(9, 151, 227)
rgb(252, 186, 3)
rgb(242, 0, 137)
rgb (247, 7, 79)
rgb(48, 38, 189)
rgb(231, 165, 240)
rgb(230, 21, 49)
rgb (252, 186, 3)
rgb(156, 242, 7)
rgb(91, 128, 189)
rgb(247, 139, 109)
rgb(224, 4, 129)
rgb(20, 13, 222)
rgb(84, 54, 94)
rgb(80, 147, 199)
rgb(117, 2, 247)
rgb(153, 146, 129)
rgb (245, 152, 2)
rgb(169, 196, 201)
rgb(5, 235, 235)
rgb(235, 190, 9)
rgb(209, 227, 11)
200, 66, 245
rgb (191, 171, 145)
rgb(126, 14, 237)
rbg(167, 124, 235)
rgb (132, 101, 173)
rbg(16, 162, 230)
rgb(217, 7, 192)
rgb(224, 224, 4)
rgb(2, 230, 230)
rgb(186, 130, 237)
rgb(235, 64, 52)